Blacks and Hispanics at higher risk for precancerous colorectal polyps

May 3, 2012

Blacks and Hispanics have a significantly higher risk of developing precancerous colorectal polyps compared with whites, according to a study by researchers at NewYork – Presbyterian Hospital/Columbia University Medical Center. The findings appeared in the online edition of Alimentary Pharmacology and Therapeutics.

"Our data suggest that we need to redouble our efforts to increase screening in areas with large numbers of racial and ethnic minorities," said lead author Benjamin Lebwohl, MD, MS, assistant professor of clinical medicine and epidemiology at NewYork – Presbyterian Hospital/Columbia University Medical Center and Columbia University's Mailman School of Public Health.

The study also found that blacks and have a higher risk of developing in the upper portion of the colon, compared with whites. "These lesions would have been missed had these patients undergone sigmoidoscopy, which examines only the lower half of the colon," said Dr. Lebwohl. "Therefore, colonoscopy, which examines the entire colon, may be preferable to sigmoidoscopy as a screening test for blacks and Hispanics."

Colorectal cancer caused an estimated 51,370 deaths in 2010 – the last year for which data are available. This type of cancer is largely preventable if caught early, in the form of precancerous polyps, or adenomas. Such polyps are effectively treated with removal during colonoscopy.

The researchers looked at rates of advanced adenomas — polyps 10 mm or larger that exhibited aggressive features under microscopic examination. "These are the kinds of polyps that we are most concerned may eventually develop into cancer," said Fay Kastrinos, MD, MPH, assistant professor of clinical medicine at NewYork – Presbyterian Hospital/Columbia University Medical Center and senior author of the study. "We found that blacks and Hispanics were roughly twice as likely to have advanced adenomas, compared with whites, after adjusting for factors such as age and family history."

Previous studies had shown that colorectal cancer incidence and mortality are higher in blacks than in whites, and that blacks are typically younger at the time of diagnosis than are whites. Little was known about the risk of adenomas among Hispanics.

In the current study, the first to compare adenomas in white, blacks, and Hispanics, the investigators analyzed data from 5,075 men and women age 50 or older who underwent first-time colonoscopy at NewYork – Presbyterian Hospital/Columbia University Medical Center from 2006 to 2010. The study population was 70 percent white, 18 percent Hispanic, and 12 percent black, with a mean age of 62. None of the subjects had signs or symptoms of colon cancer at the time of screening. At least one adenoma was detected in 19 percent of whites, 22 percent of Hispanics, and 26 percent of blacks, the researchers reported.

The findings run counter to existing statistics showing that Hispanics have a lower rate of colon cancer compared with whites. "Surprisingly, we found that Hispanics have a slightly higher rate of precancerous polyps," said Dr. Lebwohl. "This adds to other recent evidence that the rate of colorectal cancer among Hispanics may be increasing with acculturation."

Doctors generally advise patients to get an initial screening test at age 50, when overall rates of colon cancer begin to increase.

Related Stories

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.